We're delighted to add our latest Educational Series titled: Intravenous immunoglobulins (IVIg) in myasthenia gravis for exacerbations, prior to surgery and in chronic refractory disease.
This Educational Review discusses the role of IVIg in treating patients with myasthenia gravis. It also includes guiding commentary from Adjunct Associate Professor Katherine Buzzard, the Clinical Lead of the MS and Neuroimmunology Service at Eastern Health in Melbourne and a consultant in the MSNI unit at the Royal Melbourne Hospital.
Please login below to download this issue (PDF)